Exploring the performance of responsible companies in G20 during the COVID-19 outbreak

Rim El Khoury; Nohade Nasrallah; Etienne Harb; Khaled Hussainey

doi:10.1016/j.jclepro.2022.131693

Exploring the performance of responsible companies in G20 during the COVID-19 outbreak

J Clean Prod. 2022 Jun 20:354:131693. doi: 10.1016/j.jclepro.2022.131693. Epub 2022 Apr 15.

Authors

Rim El Khoury¹, Nohade Nasrallah^{2

3}, Etienne Harb⁴, Khaled Hussainey⁵

Affiliations

¹ Faculty of Business Administration and Economics, Notre Dame University-Louaize, Lebanon.
² Conservatoire National des Arts et Métiers, Le Cnam, Paris, France.
³ Laboratoire interdisciplinaire de recherche en sciences de l'action (LIRSA), France.
⁴ Research Affiliate, ESSCA School of Management, Angers, France.
⁵ Faculty of Business and Law, Portsmouth, Hampshire, UK.

Abstract

An uphill question of whether Environmental, Social, and Governance (ESG) directly impact firms' financial performance (FP) continues to vacillate between two opponent streams. In the present study, we argue that COVID-19 is an extreme event where the effect of ESG sharply manifests. We rely on cross-sectional data in the context of G20 countries for the year 2020. To avoid biased results due to governments support, we integrate four novel metrics provided by the Oxford Coronavirus Government Response Tracker (OxCGRT). We run sequential regressions (OLS; and quartiles to account for the Ingrained Income Bias (IIB) and ESG scores). We also perform robustness tests and account for the interaction between ESG and cash level. Our models were subsequently replicated for each ESG pillar. Findings indicate that ESG is beneficial during COVID-19, but the reward appears to be closely tied up to specific aspects of ESG, income level, and firm-specific variables. Results contribute to the burgeoning literature on ESG during COVID-19 by reflecting on firms' key attributes and the preponderance of government support.

Keywords: COVID-19; ESG; ESG pillars; G20; MB.; Oxford Coronavirus government response tracker (OxCGRT); ROA; ROE; TR.